R&D expenses of Moderna by type 2023

Published by
Matej Mikulic,
Mar 1, 2024
In 2023, Moderna spent some 2.34 billion U.S. dollars on infectious disease vaccines as part of its research and development expenses. The statistic illustrates the research and development expenses of Moderna Inc. in 2023, by type. Moderna became well-known for its COVID-19 vaccine Spikevax (mRNA-1273), one of the very first vaccines to be developed and approved for widely usage.

Research and development expenses of Moderna Inc. in 2023, by type (in million U.S. dollars)

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2024

Region

Worldwide

Survey time period

2023

Supplementary notes

All values are rounded.
* Program-specific expenses.

Open this statistic in...
Spanish
Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Coronavirus: the pharma and medtech response "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

12

Further Content: You might find this interesting as well

Statistics

Topics

ModernaGlobal pharmaceutical industryPfizerBioNTechVaccinations in the U.S.
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu